B cell survival in intragraft tertiary lymphoid organs after rituximab therapy. [electronic resource]
Producer: 20080715Description: 1648-53 p. digitalISSN:- 0041-1337
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antigens, CD20
- B-Cell Activating Factor -- biosynthesis
- B-Lymphocytes -- drug effects
- Biopsy
- Cell Survival -- drug effects
- Chronic Disease
- Female
- Flow Cytometry
- Follow-Up Studies
- Gene Expression
- Graft Rejection -- drug therapy
- Humans
- Immunologic Factors -- therapeutic use
- Isoantibodies -- immunology
- Kidney Transplantation -- immunology
- Male
- Prospective Studies
- RNA -- genetics
- Reverse Transcriptase Polymerase Chain Reaction
- Rituximab
- Transplantation, Homologous
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.